Accounting giant Deloitte Touche Tohmatsu has admitted in a Federal Court defence that it expects its partners to retire at the age of 62, but it says there is no obligation for partners to depart the firm at that age.
The Full Federal Court has granted a limited appeal in the Kingdom of Spain’s challenge to a judgment enforcing a $375 million arbitration award over two renewable energy investments, ordering a redrafting of the primary judge’s orders but rejecting claims that Spain was immune as a foreign state from enforcement of the award.
Andrew Hopkins has resigned from his position as group CEO of automotive repair firm AMA and has discontinued his lawsuit against the company despite a Federal Court injunction barring his dismissal amid allegations of fraud.
Automotive firm AMA Group will seek to discharge an injunction preventing it from dismissing a CEO who has been accused of defrauding the company of “hundreds of thousands of dollars” and damaging its reputation with major partners.
Botox maker Allergan has appealed a court judgment tossing most of trade mark case against an Australian cosmetics company that sells topical creams as Botox alternatives.
A partner bringing a $3.8 million age discrimination lawsuit against Deloitte Touche Tohmatsu will not seek to replead claims struck out earlier this month that the accounting giant made misrepresentations to Rio Tinto.
Deloitte Touche Tohmatsu has succeeded in striking out claims that it made misrepresentations to Rio Tinto when it appointed a partner nearing the mandatory retirement age to a five-year project with the mining giant.
Deloitte Touche Tohmatsu is seeking to strike out the misleading and deceptive conduct claims in a $4 million age discrimination lawsuit brought by a former partner, calling them “farcical” and “absurd”.
Accounting firm Findex has lost an appeal of a court’s judgment tossing its case against a former financial advisor, despite the court finding he had poached the company’s clients and caused $742,000 in losses.
Botox maker Allergan has lost a lawsuit that accused an Australian cosmetics company that sells topical creams as an alternative to Botox injections of infringing its Botox trade mark.